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Abstract
Background: Fluoroscopy is a frequently used examination in clinical routine without appropriate research evaluation
latest hardware and software equipment.
Purpose: To evaluate the feasibility of low-dose pulsed video-fluoroscopic swallowing exams (pVFSE) to reduce dose
exposure in patients with swallowing disorders compared to high-resolution radiograph examinations (hrVFSE) serving
as standard of reference.
Material and Methods: A phantom study (Alderson-Rando Phantom, 60 thermoluminescent dosimeters [TLD]) was
performed for dose measurements. Acquisition parameters were as follows: (i) pVFSE: 76.7 kV, 57mA, 0.9 Cu mm, pulse
rate/s 30; (ii) hrVFSE: 68.0 kV, 362mA, 0.2Cu mm, pictures 30/s. The dose area product (DAP) indicated by the detector
system and the radiation dose derived from the TLD measurements were analyzed. In a patient study, image quality was
assessed qualitatively (5-point Likert scale, 5¼ hrVFSE; two independent readers) and quantitatively (SNR) in 35 patients
who subsequently underwent contrast-enhanced pVFSE and hrVFSE.
Results: Phantom measurements showed a dose reduction per picture of factor 25 for pVFSE versus hrVFSE images
(0.0025mGy versus 0.062mGy). The DAP (mGym2) was 28.0 versus 810.5 (pVFSE versus hrVFSE) for an average
examination time of 30 s. Direct and scattered organ doses were significantly lower for pVFSE as compared to
hrVFSE (P< 0.05). Image quality was rated 3.9 0.5 for pVFSE versus the hrVFSE standard; depiction of the contrast
agent 4.8 0.3; noise 3.6 0.5 (P< 0.05); SNR calculations revealed a relative decreased of 43.9% for pVFSE as
compared to hrVFSE.
Conclusion: Pulsed VFSE is feasible, providing diagnostic image quality at a significant dose reduction as compared to
hrVFSE.
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Introduction
Dysphagia is a widespread diagnosis with a great variety
of underlying pathologies (1,2), such as cerebrovascular
events, neurodegenerative diseases, and cancer of the
nasopharyngeal and upper gastrointestinal tract (3,4).
Video-fluoroscopic swallowing exams (VFSE) are recog-
nized as the standardof reference for imagingdisordersof
the swallowing process (5,6). In addition to the primary
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diagnosis, VFSE serve as a helpful diagnostic tool for
therapyplanningand follow-up evaluation (7,8). For pre-
cise diagnosis, good contrast and high temporal reso-
lution are required at a preferably low dose exposure (9).
Although frequently used in daily clinical routine,
very few studies have been published on the radiation
dose efficiency of these examinations (10,11). In particu-
lar, little is known about the actual organ dose absorbed
by radiosensitive organs (12,13) given the fact that the
applied dose during VFSE is usually indicated by the
detector system as dose area product (DAP) or entrance
skin dose (ESD) (14,15). This dose value does not take
into account that some tissues are more susceptible to
radiation damage than others (13). However, this is
important to know since the applied radiation dose
can reach or exceed those of modern low-dose cervical
CT protocols (16), especially when VFSE is repeatedly
performed at a high temporal resolution to evaluate the
swallowing capability of fluid and different food consis-
tencies (e.g. mush, pudding, solid food). Therefore,
phantom studies are necessary to provide reliable dose
values in order to facilitate adequate risk stratification in
favor of increased patient safety (17). Moreover, exam-
ination methods and technical equipment of fluoro-
scopic examinations were continuously developed
during the last decades from analogue film-screen tech-
niques to digital detector systems including last image
hold capability, pulsed fluoroscopy, and improved beam
filtration with no appropriate research evaluating the
clinical value and feasibility of these latest hardware
and software developments for VFSE (9,18).
Therefore, the purpose of this study was to evaluate
the effectiveness and feasibility of a modern flat-panel
detector system with state-of-the-art low-dose digital
pulsed protocols for reducing dose exposure of VFSE
(pVFSE) as compared to high-resolution digital radio-
graph examinations (hrVFSE) serving as a standard of
reference. Our hypothesis was that pVFSE allows for a
significant dose reduction, especially in distant radio-
sensitive organs at a retained diagnostic image quality.
Material and Methods
This retrospective study received approval by the local
ethics committee of the Ludwig-Maximilians-
University, Munich, Germany and written informed
consent was waived.
Detector system and protocols
All examinations were performed with a multifunc-
tional flat-panel detector system (Artis Zee MP,
Siemens Healthcare, Erlangen, Germany) by the
same radiologist (AP). A microprocessor-controlled
high-frequency X-ray generator (100 kW at 100 kV)
with an automatic X-ray control system was used.
Focal spot size was 0.3/0.6/1.0mm; nominal power
(¼0W) of the X-ray tube and power according to
IEC (¼300W) was 18/52/100 kW respectively 15/40/
80; maximal exposure voltage 125 kV.
Detector size was 30 40 cm (48m diagonal entrance
plane; cesium iodide [CsI] scintillator, amorphous
silicion [a-Si]) with a pixel size of 154 154mm, 14-bit
digitization depth, and a spatial resolution of
3.25LP/mm. The resolution was 512 512 for pVFSE
images and 1024 1024 for hrVFSE examinations.
Preset algorithms were utilized to improve image quality
in terms of noise, contrast, and brightness.
Standard protocol settings comprised copper filter-
ing (pVFSE; 0.9mm; hrVFSE, 0.2mm) and a pulse/
frame rate of 30 images/s. The pVFSE was operated
with 76.7 kV and 57mA whereas 68.0 kV and 362mA
were used for the hrVFSE examinations. To further
reduce dose exposure, last image hold capability allow-
ing for radiation-free collimator adjustment and object
positioning was used when necessary to plan the further
examination. The field of view (FOV) was chosen as
small as possible.
Phantom studies
In our institution, hrVFSE was the clinical standard
examination for patients with swallowing disorders.
After the application of a new software package,
pVFSE replaced hrVFSE as examination of choice
due to its substantially reduced dose exposure. To sys-
tematically assess the differences in dose exposure
between the two examination protocols, we used an
anthropomorphic male Alderson-Rando Phantom
(Humanoid Phantom, Type RT200, Humanoid
Systems, Carson, CA, USA), which represents a stan-
dardized male patient (175 cm height and 73.5 kg
weight) and is considered equivalent to human body
tissue in terms of X-ray absorption and scattering.
Sixty thermoluminescent dosimeters (TLD, LiF
(Lithiumfluorid), TLD Type-100, 1 6mm, Harshaw,
Chemical Company, Solon, OH, USA) were placed in
relevant organs of interest comprising the salivary
glands, the thyroid, the red bone marrow, and the
esophagus in the direct radiation beam and the eyes,
the thymus, the lungs, and the gonads in the scattered
beam. A phantom scheme showing the TLD distribu-
tion is provided in Fig. 1.
For more reliable results, every organ was equipped
with at least two TLD. In order to reduce measurement
errors, images (pVFSE and hrVFSE) were acquired at a
pulse rate of 30 images/s until a cumulative dose of
500mGy was indicated by the detector system. TLD
were recalibrated before each measurement to ensure
reliable dose values. Dose values for direct and
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scattered organ dose (mGy) were calculated with the
mean dose of all TLD placed in an individual organ
(n¼ 2–4). The presented values of the DAP (mGym2)
and absorbed organ doses derived from the TLD meas-
urements were calculated for the duration of an average
examination observed in the patient study (see below).
Exposure was performed with a tube distance of
35.5 cm to the phantom and a distance of 31.0 cm to
the detector. The FOV involved the oral cavity and the
oro-/hypopharynx (Fig. 2).
Patient study
In addition to the dose measurements in the phantom
study, we performed a patient study to evaluate the
image quality of the pVFSE protocol in clinical routine
in comparison to the former hrVFSE standard proto-
col. For this reason, we retrospectively included 35
patients, who subsequently underwent contrast-
enhanced (Imeron 400, Bracco, Milan, Italy; Peritrast
400, Dr. Franz Ko¨hler Chemie GmbH, Bensheim,
Germany) hrVFSE before the software update and rou-
tine follow-up pVFSE after the software update. All
examinations were clinically indicated for further evalu-
ation of swallowing disorders and were performed by
the same examiner. Exclusion criteria included incom-
plete examinations due to severe aspiration or poor
physical condition of the patient and patients aged
under 18 years.
Image quality analysis: All images were appraised
on a dedicated workstation (syngoMMWP VE26A;
Siemens Healthcare, Erlangen, Germany). Image
quality was independently assessed by two radiolo-
gists (AP, MN) with 3 and 6 years of experience,
respectively, in fluoroscopy. Images were evaluated
in a random order and both readers were blinded
to the clinical diagnosis and the type of examination
protocol. All ratings used a five-point Likert scale
comprising the following parameters: overall image
quality; depiction of the contrast agent; subjective
image noise. Per definition, qualitative image param-
eters were rated as 5 in hrVFSE examinations, indi-
cating the most satisfying acquisition respectively the
least artifacts, as this was the former routine clinical
examination, thus serving as standard of reference for
the pVFSE protocol.
Signal-to-noise ratio (SNR) and relative SNR dif-
ferences (SNR) were calculated to obtain objective
image parameters by placing a region of interest
(ROI; similar size (ca. 2 cm2) and position in
pVFSE and hrVFSE) in the most homogeneous
part of cervical soft tissue using the following
equations:
SNR ¼ mean signalROI=mean SDROI
  ð1Þ
SNR%¼ 1 SNRpVFSE=SNRhrVFSE
  100 ð2Þ
Statistical analysis
All statistical analyses were performed using SPSS
(Version 22, IMB, Armonk, NY, USA). Qualitative
reading scores were compared using the Wilcoxon-
signed-rank test. For comparison of quantitative mea-
surements paired t-test was conducted. P values
below 0.05 were assumed to indicate statistical
significance.
Fig. 1. Thermoluminescent dosimeter distribution scheme of
the Alderson Rando Phantom.
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Inter-reader agreement was assessed by calculating
Cohen’s kappa, which was interpreted as follows: <0.2
poor correlation; 0.2–0.4 fair correlation; 0.4–0.6 mod-
erate correlation; 0.6–0.8 substantial correlation; and
>0.8 excellent correlation.
Results
Phantom study
The cumulated phantom dose measurement showed a
general dose reduction per picture of factor 25 for
pVFSE versus hrVFSE images (0.0025mGy versus
0.062mGy).
To ease comparability and to provide reference
values for clinical routine the presented results for
both, DAP and direct as well as scattered radiation
levels were calculated for an average acquisition time
of 30 s due to the mean examination time of 34 s (range,
11–106 s) in the patient study (see below). The resulting
DAP (mGym2) indicated by the detector system was
28.0 for pVFSE and 810.5 for hrVFSE examinations
(factor 29; thinsp;hrVFSE versus pVFSE).
Direct and scattered organ dose (mGy) was signifi-
cantly lower (P< 0.05) for pVFSE versus hrVFSE
images in all observed organs. As to be expected, high-
est dose exposure was measured in the direct beam (sal-
ivary glands, thyroid, esophagus, bone marrow).
Scattered radiation dose decreased continuously with
growing distance from the FOV, with highest radiation
levels next to the FOV (eyes, thymus, lungs) and no
measurable radiation dose in the gonads (male and
female). Detailed results of the examined organs are
provided in Table 1.
Patient study
VFSE with both examination protocols was success-
fully completed in all 35 patients (mean age, 66 16
years; age range, 24–94 years; 19 men) and all patients
were included in the final analysis. Unclear dysphagia
was the most common diagnosis (n¼ 12), followed by
larynx carcinoma (n¼ 6) and oropharynx carcinoma
(n¼ 6), Zenker’s diverticulum (n¼ 4), esophagus car-
cinoma (n¼ 3), and others (n¼ 4). The average fluoro-
scopic acquisition time was 34 s (range, 11–106 s)
Fig. 2. FOV for image acquisition (pVFSE and hrVFSE) in the phantom study.
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depending on the physical condition and clinical diag-
nosis of the patient.
Image analysis: Overall image quality was rated
3.9 0.5 for pVFSE as compared to the hrVFSE
standard (¼ 5; P< 0.05). The depiction of the contrast
agent was graded with 4.8 0.3 versus 5.0 0.0;
P< 0.05 (pVFSE versus hrVFSE, respectively).
Subjective image noise was markedly higher in
pVFSE images in comparison to the hrVFSE standard
(3.6 0.5; P< 0.05) with substantial to excellent
inter-reader agreement for all evaluated parameters
(0.68–0.91).
SNR calculations revealed significantly lower values
for the pVFSE (48.0 22) as compared to the hrVFSE
images (88.5 36.6; P< 0.001) resulting in a SNR of
43.9 19.1%.
Exemplary images of the most common diagnoses
are provided in Figs. 3–5.
Discussion
In this study, we evaluated the clinical value and
feasibility of the latest technical advances for video-
fluoroscopic swallowing exams. We could demonstrate
that low-dose digital pulsed protocols acquired with a
modern flat-panel detector system allow for a signifi-
cant dose reduction while retaining diagnostic image
quality.
These are important results considering the frequent
use in daily clinical routine (19,20). In particular,
patients with an above-average examination time due
to passage disorders or patients repeatedly examined in
order to assess postoperative outcome can cumulate a
considerably high radiation dose with conventional
hrVFSE protocols, particularly when different food
consistencies are evaluated with a consequently pro-
longed examination time. In this context, our results
indicate that digital pulsed VFSE using state-of-the-
art low-dose protocols is an effective approach
to reduce dose exposure and seems a valuable
Fig. 3. pVFSE (a) and hrVFSE (b) images of a 52-year-old woman with dysphagia and recurrent aspirations post stroke. Images after
oral contrast agent administration show contrast agent pooling superior to the epiglottis (arrow) and moderat intratracheal aspiration
(arrow head) similarly detecable in pVFSE and hrVFSE.
Table 1. Absorbed organ doses (mGy) for an average acquisi-
tion time of 30 seconds in direct and scattered radiation for
hrVFSE and pVFSE.
hrVFSE pVFSE
Scattered radiation (mGy)
Eyes 2.43 0.11
Thymus 2.01 0.07
Lungs 1.38 0.05
Gonads male 0 0
Gonads female 0 0
Direct radiation (mGy)
Salivary glands 39.00 1.68
Thyroid 33.03 1.29
Esophagus 23.91 1.02
Bone marrow 3.03 0.17
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alternative to replace standard of reference high-resolu-
tion VFSE examinations.
As expected and shown in our phantom study,
organs in the direct beam showed the highest radiation
levels whereas scattered dose exposure in distant organs
is negligible low. In the gonads, for instance, no dose
exposure could be measured at all. Thus, there appears
no significant risk of gonadal radiation damage during
pVFSE, even if frequent examinations should be neces-
sary. Our results are consistent with Iwai et al., who
also evaluated organ doses of swallowing examinations
in a phantom study (12). Due to their different detector
system and examination protocols the results cannot be
compared absolutely; however, the distribution pattern
of the radiation dose was similar as in our study.
Others, like Zammit-Maempel (5) or Kim et al. (10),
only estimated the total effective dose of VFSE using
standardized Monte-Carlo derived conversion factors,
however, at the cost of a remaining uncertainty regard-
ing the actual dose absorbed. Nevertheless, this is a
commonly used approach given that up till now the
DAP is the standard of reference to quantify the dose
exposure of fluoroscopic examinations. However, this
dose value does not consider tissue specific radiation
susceptibility (13,21) and the DLP-derived estimation
of the effective dose lacks the information of individual
organ doses, although they are considered to provide
the most detailed insight in the radiation burden of the
patient (22). Therefore, the results of our phantom
measurements presented in this study may serve as an
orientation of the average organ dose exposure during a
standard VFSE.
The results of our patient study revealed that low-
dose pVFSE provide a sufficient image quality for a
reliable diagnosis of all evaluated indications as com-
pared to the hrVFSE reference standard although the
relative SNR of pVFSE decreased by approximately
45%. However, this had no relevant effect on diagnos-
tic performance in clinical routine, since all pVFSE
were rated as diagnostic and no additional hrVFSE
or follow-up examination due to insufficient image
quality was necessary to allow for an unequivocal diag-
nosis. Therefore, we consider low-dose pVFSE as a
promising approach to increase patient safety by sub-
stantially reducing dose exposure without sacrificing a
satisfying image quality. As mentioned above, this is of
great importance, since frequent examinations can
result in a high cumulative radiation dose with the
risk of long-term radiation effects (23). Supported by
these results, we have replaced the former hrVFSE ref-
erence standard by the pVFSE protocol as routine clin-
ical examination of choice in patients with swallowing
disorders.
As mentioned above, technical equipment has been
continuously developed in the last decades with no
appropriate research evaluating quality standards of
both examination methods and hardware devices for
VFSE. Relevant advances allowing for reduced dose
exposure are, among others, pulsed image acquisition,
last image-hold capability, automatic dose control,
and beam filtering (24,25), which were also applied
in this study but have yet only been evaluated in the
setting of heart catheter examinations and in pediatric
radiology (24,26). With this study we provide an
update and overview of the effectiveness and clinical
feasibility of the latest hardware and software equip-
ment for standard VFSE examinations in clinical
routine.
Some limitations of this study need to be addressed.
First, it is well-known that fluoroscopic examinations
are highly dependent to individual operator practice
regarding duration, accurate superimposition, and
Fig. 4. pVFSE (a) and hrVFSE (b) images of a 69-year-old male patient with a small diverticulum in the proximal esophagus (arrow)
similarly detectable in pVFSE and hrVFSE images.
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correct patient distance to the tube with direct effects
on the resulting dose exposure (13). To rule out these
inter-operator effects on the tested examination proto-
cols, we only included examinations obtained by a
single examiner and normalized the dose results for
an average examination time of 30 s. However, these
results may only serve as a general orientation, because
no information about inter-observer performance was
taken into account. Furthermore, it is not possible to
simulate the administration of contrast agent in the
Alderson-Rando Phantom to evaluate its effect on
the radiation dose, whereas dose measurements in the
patient study were performed after contrast agent
administration. Additionally, the phantom dose meas-
urements were only performed once and therefore no
information about re-test repeatability is available and
it is not possible to differentiate the individual contri-
bution of the different dose-saving methods and soft-
ware algorithms to the overall dose reduction achieved
by the pVFSE protocol.
In conclusion, pulsed VFSE with a modern flat-
panel detector system provides diagnostic image quality
at a significant dose reduction as compared to standard
of reference hrVFSE. Scattered radiation levels in dis-
tant radiosensitive organs are negligible low with no
severe risk of radiation damage.
Fig. 5. pVFSE (a, c) and hrVFSE (b, d) images of a 73-year-old male patient post larnygectomie due to larynx carcinoma. Depiction of
contrast agent was rated equivalent in pVFSE and hrVFSE images whereas image nosie was rated higher in pVFSE (a, c) images.
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